Lymphocyte's activation and apoptosis after coronary artery bypass graft: A comparative study of two membrane oxygenators - One with and another without a venous-arterial shunt

ASAIO Journal

Volumn 50, Issue 6, 2004, Pages 611-618

  Leães, Paulo E ^a   Neumann, Jorge ^a   Jung, Luiz A ^a   Blacher, Celso ^a   Lucchese, Fernando ^a   Clausell, Nadine ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; IMMUNOLOGY; SURGERY;

APOPTOSIS; CARDIOPULMONARY BYPASS (CPB);

OXYGEN;

CD3 ANTIGEN; CD69 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 2 RECEPTOR; LIPOCORTIN 5;

ADULT; APOPTOSIS; ARTERIOVENOUS SHUNT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FLOW CYTOMETRY; HUMAN; INTERMETHOD COMPARISON; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPENIA; MALE; OXYGENATOR; POSTOPERATIVE COMPLICATION; PROTEIN EXPRESSION; VALIDATION PROCESS;

AGED; ANNEXIN A5; ANTIGENS, CD; APOPTOSIS; BIOLOGICAL MARKERS; CORONARY ARTERY BYPASS; EQUIPMENT DESIGN; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; OXYGENATORS, MEMBRANE; POSTOPERATIVE PERIOD;

EID: 10044242510     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MAT.0000144590.98621.4F     Document Type: Article

References (27)

1. Hall RI, Smith MS, Rocker G: The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85: 766-782, 1997.
2. Savaris N, Polanczyk C, Clausell N: Cytokines and troponin-I in cardiac dysfunction after coronary artery grafting with cardiopulmonary bypass. Arq Bras Cardiol 77: 114-119, 2001.
3. Matata BM, Sosnowski AW, Galiñanes M: Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 69: 785-791, 2000.
4. Czerny M, Baumer H, Kilo J, et al: Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17: 737-742, 2000.
5. Gu YJ, Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CRH: Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55: 917-922, 1993.
6. Richter JA, Meisner H, Tassani P, Barankay A, Dietrich W, Braun SL: Drew-Anderson technique attenuates systemic inflammatory response syndrome and improves respiratory function after coronary artery bypass grafting. Ann Thorac Surg 69: 77-83, 1999.
7. Moraes DJ, Moraes MC, Dias JR, et al: Uso de oxigênio puro e shunt veno-arterial nos oxigenadores de membrana. Rev Bras Cir Cardiovasc 12: 77-82, 1997.
8. Moraes M, Dias J, Moraes Z, Novaes M, Holanda N, Junqueira D: Perfusion for cardiac surgery using venous arterial shunt and pure oxygen in membrane oxygenators: forty to fifty per cent of the venous blood recirculate and do not pass through the oxygenator. J Am Coll Cardiol 31: 405C, 1998.
9. Ihnken K, Winkler A, Schlensak C, et al: Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg 116: 327-334, 1998.
10. de Vroege R, Wagemakers M, te Velthuis H, et al: Comparison of three commercially available hollow fiber oxygenators: Gas transfer performance and biocompatibility. ASAIO J 47: 37-44, 2001.
11. Misoph M, Babin-Ebell J, Schwender W, Grossmann R, Keller F, Elert O: Response of the cellular immune system to cardiopulmonary bypass in vivo. Thorac Cardiovasc Surg 47: 217-223, 1997.
12. Markewitz A, Lante W, Franke A, Marchi K, Kuhlmann WD, Weinhold C: Alterations of cell-mediated immunity following cardiac operations: Clinical implications and open questions. Shock 16: 10-15, 2001.
13. Shimaoka M, Hosotsubo K, Sugimoto M, Sakaue G, Taenaka N, Yoshyia I: The influence of surgical stress on T cells: Enhancement of early phase lymphocyte activation. Anesth Analg 87: 1431-1435, 1998.
14. Chello M, Mastroroberto P, Quirino A, et al: Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg 73: 123-129, 2002.
15. O'Connor GT, Plume SK, Olmstead EM, et al: A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting: The Northern New England Cardiovascular Disease Study Group. JAMA 266: 803-809, 1991.
16. Ziegler SF, Ramsdell F, Alderson MR: The activation antigen CD69. Stem Cells 12: 456-465, 1994.
17. Ryhaenem P, Huttunem K, Llonem J: Natural killer cell activity after open heart surgery. Acta Anaesthesiol Scand 28: 490-492, 1984.
18. Blacher C, Neumann J, Marques ME, et al: Off-pump coronary artery bypass surgery does not reduce lymphocyte activation. Int J Cardiol in press.
19. Bone RC: Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24: 1125-1128, 1996.
20. Hisatomi K, Isomura T, Kawara T, et al. Changes in lymphocyte subsets, mitogen responsiveness, and interleukin-2 production after cardiac operations. J Thorac Cardiovasc Surg 98: 580-591, 1989.
21. Bertho AL, Santiago MA, Coutinho SG: Flow cytometry in the study of cell death. Mem Inst Oswaldo Cruz 95: 429-433, 2000.
22. Vermes I, Haanen C, Stephens-Nakken H, Reutelingsperger CPM: A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 184: 39-51, 1995.
23. Tonnesen E, Brinklov MM, Christensen NJ, Olesen AS, Madsen T: Natural killer cell activity and lymphocyte function during and after coronary artery bypass grafting in relation to the endocrine stress response. Anesthesiology 67: 526-533, 1987.
24. Frass OM, Buhling F, Tager M, et al: Antioxidant and antiprotease status in peripheral blood and BAL fluid after cardiopulmonary bypass. Chest 120: 1599-1608, 2001.
25. Brody JI, Pickering NJ, Fink GB, Behr E: Altered lymphocyte subsets during cardiopulmonary bypass. Am J Clin Pathol 87: 626-628, 1987.
26. Ide H, Kakiuchi T, Furuta N, et al: The effect of cardiopulmonary bypass on T cells and their subpopulations. Ann Thorac Surg 44: 277-282, 1987.
27. Roth JA, Golub SH, Cukingnam RA, Brazier J, Morton DL: Cell-mediated immunity is depressed following cardiopulmonary bypass. Ann Thorac Surg 31: 350-356, 1981.